Valiant Laboratories Balance Sheet Health
Financial Health criteria checks 3/6
Valiant Laboratories has a total shareholder equity of ₹2.3B and total debt of ₹1.2B, which brings its debt-to-equity ratio to 49.7%. Its total assets and total liabilities are ₹3.6B and ₹1.3B respectively.
Key information
49.7%
Debt to equity ratio
₹1.15b
Debt
| Interest coverage ratio | n/a |
| Cash | ₹1.19b |
| Equity | ₹2.32b |
| Total liabilities | ₹1.29b |
| Total assets | ₹3.61b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: VALIANTLAB's short term assets (₹1.9B) exceed its short term liabilities (₹218.5M).
Long Term Liabilities: VALIANTLAB's short term assets (₹1.9B) exceed its long term liabilities (₹1.1B).
Debt to Equity History and Analysis
Debt Level: VALIANTLAB has more cash than its total debt.
Reducing Debt: Insufficient data to determine if VALIANTLAB's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: VALIANTLAB's debt is not well covered by operating cash flow (14.1%).
Interest Coverage: Insufficient data to determine if VALIANTLAB's interest payments on its debt are well covered by EBIT.